DANIEL RHOADS: Open Payments
NPI 1316046162 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 65 payments from 15 companies in 2025. Trend: 2023 $2,134 · 2024 $3,000 · 2025 $1,304
Food & beverage: $1,219Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $309 |
| ABBVIE INC. | 17 | $299 |
| UCB, Inc. | 6 | $121 |
| Lilly USA, LLC | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| PFIZER INC. | 3 | $78 |
| Amgen Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| LEO Pharma Inc. | 1 | $48 |
| Incyte Corporation | 2 | $34 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Bimzelx, Sotyktu, CIBINQO, EBGLYSS, OTEZLA.
Industry payments across WA — which companies pay providers there.
